Acrux DDS Pty Ltd.
Records under this name other than the patents Acrux DDS Pty Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,177,449 | Spreading implement Lapsed on the fee record Ended May 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2024 | From the USPTO record |
| US 9,289,586 | Spreading implement Lapsed on the fee record Ended Mar 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2024 | From the USPTO record |
| US 10,449,343 | Device for Dispensing and Applying a Liquid Lapsed on the fee record Ended Oct 22, 2023 · High confidence | Lapsed on the fee record | Ended Oct 22, 2023 | High confidence |
| US 6,978,945 | Dispensing device Term ended Term ended Jul 31, 2022 · From the USPTO record | Term ended | Term ended Jul 31, 2022 | From the USPTO record |
| US 8,435,944 | Method and composition for transdermal drug delivery Lapsed on the fee record Ended May 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2021 | From the USPTO record |
| US 8,357,393 | Transdermal delivery rate control using amorphous pharmaceutical compositions Lapsed on the fee record Ended Jan 22, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2021 | From the USPTO record |
| US 9,180,194 | Method and composition for transdermal drug delivery Lapsed on the fee record Ended Nov 10, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 10, 2019 | From the USPTO record |
| US 9,078,810 | Transdermal delivery system Lapsed on the fee record Ended Jul 14, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2019 | From the USPTO record |
| US 8,993,520 | Method and composition for transdermal drug delivery Lapsed on the fee record Ended Mar 31, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 31, 2019 | From the USPTO record |
| US 8,071,075 | Dermal penetration enhancers and drug delivery systems involving the same Term ended Term ended Mar 19, 2019 · From the USPTO record | Term ended | Term ended Mar 19, 2019 | From the USPTO record |